Susquehanna International Group, LLP Sangamo Therapeutics, Inc Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 773,266 shares of SGMO stock, worth $402,098. This represents 0.0% of its overall portfolio holdings.
Number of Shares
773,266
Previous 1,809,550
57.27%
Holding current value
$402,098
Previous $1.19 Million
65.08%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding SGMO
# of Institutions
125Shares Held
50.6MCall Options Held
1.1MPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.87 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.2 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.56 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.45 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.21 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $81.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...